4Xu J,Kim GM,Ahmed SH,et al.Glucocorticoid receptormediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury[J].J Neurosci,2001,21(1):92～97.
5Bracken MB,Shepard MJ,Collins WF,et al.A randomized,controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury.Results of the Second National Acute Spinal Cord Injury Study[J].N Engl J Med,1990,322:1405～1411.
6Bracken MB,Shepard MJ,Holford TR,et al.Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury.Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial.National Acute Spinal Cord Injury Study[J].JAMA,1997,277:1597～1604.
7Ji B,Li M,Budel S,et al.Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury[J].Eur J Neurosci,2005,22(3):587～594.
8Yip CC,Chng NW,Au Eong KG,et al.Low-dose intravenous methylprednisolone or conservative treatment in the management of traumatic optic neuropathy[J].Eur J Ophthalmol,2002,2(4):309～314.
9Fisher AW,holfelder H.Lokales amyloid in gehim:eine spatfolge von routgenbestrahlungen[J].Dtsch Z Chir,1930,227:475～483.
10Plowman PN.Stereotactic R.Ⅷ.The classification of postradiation reactions[J].Br J Neurosurg,1999,13(3):256～264.
